Clinical Trials Directory

Trials / Completed

CompletedNCT07156344

Assessing Vulnerability and Outcomes of Intracranial Atherosclerotic Plaques

An Observational Cohort Study on the Identification and Outcome Evaluation of Intracranial Atherosclerotic Plaque Vulnerability

Status
Completed
Phase
Study type
Observational
Enrollment
3,849 (actual)
Sponsor
Xuanwu Hospital, Beijing · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers

Summary

This prospective cohort study aims to establish a large-scale cohort for primary stroke prevention in asymptomatic intracranial atherosclerosis (ICAS). Objectives include: characterizing risk factor and stenotic artery distributions; determining optimal TCD screening sentinel arteries; observing plaque progression/regression via HR-MRI; establishing vulnerable plaque evaluation systems through stroke event follow-up; and developing cognitive decline prediction models integrating hemodynamic parameters. All procedures (TCD, HR-MRI, neuropsychological assessments) are routine clinical examinations with minimal risk. Participation is voluntary. Initial TCD and qualifying HR-MRI scans incur standard fees; all follow-up imaging and neuropsychological assessments post-enrollment are provided free of charge.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTProgression and Outcome of Intracranial Atherosclerosis"Progression and Outcome of Intracranial Atherosclerosis" is the primary endpoint; all others are secondary endpoints. Stroke defined as any stroke and new ipsilateral stroke (including ischemic and hemorrhagic stroke) associated with vascular stenosis.

Timeline

Start date
2019-01-01
Primary completion
2025-04-30
Completion
2025-04-30
First posted
2025-09-05
Last updated
2025-09-05

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT07156344. Inclusion in this directory is not an endorsement.